Search
for
Sort by
Research 301–330 of 1000+
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Immune therapies for alopecia areata: evidence and new perspectives
- Citrullination at the Inflammatory Skin Barrier
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- 477 How Cannabidiol Supports Hair Growth: From Epigenetics to the Scalp Microbiome
- Review of efficacy of baricitinib in the treatment of alopecia areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Time-course RNA-seq analysis reveals stage-specific and melatonin-triggered gene expression patterns during the hair follicle growth cycle in Capra hircus
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- A review of Janus kinase inhibitor use in scarring alopecia
- Janus kinase inhibitors for alopecia areata: A narrative review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Pathomechanisms of immune-mediated alopecia
- Baricitinib: A Review in Severe Alopecia Areata
- Exploring novel management options for alopecia areata
- Quercetin Promotes Production of Secondary Hair Follicle Stem Cells in Cashmere Goat: A Mechanistic Study
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases